Delphine O’Rourke is a partner in the Life Sciences group and Healthcare practice at Goodwin Procter LLP. She is trusted counsel to health industry leaders. Ms. O’Rourke counsels health companies, hospitals & healthcare systems, and investors on the regulatory frameworks that drive their business. Clients rely on her deep knowledge of healthcare law and policy as well as her experience as a health care executive and in-house general counsel. She served as Associate General Counsel of Ascension and in her decades plus with Ascension, she served in legal roles of increasing responsibility for the $29 billion health enterprise.

Ms. O’Rourke’s healthcare regulatory practice focuses on:

• Compliance with federal laws & regulations governing access, delivery and payment for medical care in the United States including EMTALA, the federal Anti-Kickback Statute, Stark Law, patient care issues, medical staff matters, licensure, accreditation and tax exemption
• Strategic affiliations & investments including complex provider and multi-system transactions, due diligence on behalf of private equity clients and critical supply chain relationships
• Emergency management, public health & crisis communications including currently advising a wide range of companies and providers on the legal issues relating to COVID-19

Ms. O’Rourke is a regular speaker on cutting edge healthcare regulatory developments and contributor to leading legal and industry publications and podcasts including Modern Healthcare, Law360 and the American Health Law Association. She is nationally recognized for her commitment to the advancement of women and inclusionary leadership.

Ms. O’Rourke also maintains an active pro bono practice.